08:30-09:00- Compliance in Pediatric IBD: can we do better?
Dror shouval, Pediatric Gastroenterology Unit, Edmond and Lily Safra Children’s Hospital, Tel
Hashomer
Chair: Sarit Peleg
Satellite session sponsored by 
09:00-10:40 Session 3
Chair: Orly Eshach- Adiv, Garah Jamal
09:00-09:30- Intestinal regeneration
Nikhil Thapar, Great Ormond Street Hospital NHS Foundation Trust and UCL Institute
of Child Health, United Kingdom
09:30-09:40- The Prevalence of Celiac Antibodies in Type-1 Diabetes Patients Depends on the Duration
of Diabetes Mellitus
Mordechai Slae, Hadassah Hebrew University Medical Center, Kuppat Cholim Clallit
09:40-09:50- Ethnic disparities in phenotype and histopathology profile in children with Celiac Disease
Efrat Broide, Pediatric Gastroenterology Unit, Assaf Harofeh Medical Center
09:50-10:00 –CD patients in deep remission harbor a high dysbiosis index similar to active CD at
diagnosis, yet both are higher in comparison to healthy controls
Yael Haberman for the Israeli IBD Research Nucleus (IIRN)
10:00-10:10- Association between infliximab trough levels, antibodies to infliximab and clinical
remission in pediatric patients with inflammatory bowel diseases
Batia Weiss, Pediatric Gastroenterology Unit , Edmond and Lily Safra Children's Hospital, Tel Hashomer
10:10-10:20 –Assessment of Vitamin A status among newly diagnosed Celiac disease patients.
Yael Weintraub, The Pediatric Gastroenterology Unit of "Dana-Dwek" Children's Hospital,
Tel Aviv, Israel
10:20-10:30- Is Helicobacter pylori chronic infection associated with the severity of celiac disease in
children?
Tzipora Shalem, Pediatric Gastroenterology Unit, Assaf Harofeh Medical Center, Israel
10:30-10:40- Clinical and phenotypic differences in inflammatory bowel disease among Arab and Jewish
children in Israel
Firas Rinawi, Institute of Gastroenterology, Nutrition and Liver Diseases, Schneider Children's Medical
Center of Israel, Petach Tikva
10:40- 11:10- Coffee break and visit to the exhibit hall
Sponsored by
11:10-11:40- Innovation in IBD in the era of individualized medicine
Efrat Broide, Assaf Harofeh Medical Center
Chair: Batia Weiss
Satellite session sponsored By 
11:40- 13:20 Session 4
Chair: Ilana Weintraub, Aaron Klar
11:40-12:20 Microbiome in IBD
Microbiological Aspect
Ilan Youngster, Senior Physician, Pediatric Infectious Diseases, Assaf
Harofeh Medical Center
Gastroenterological Aspect
Dror shouval, Pediatric Gastroenterology Unit, Edmond and Lily Safra
Children’s Hospital, Tel Hashomer
12:20-12:30- The antiFibrotic effect of Aramchol on liver Fibrosis in TAA animal model
Shimon Reif, Department of Pediatrics Hadassah Ein Kerem Medical Center
12:30-12:40- Biliatresone, a toxic model of biliary atresia in animals, causes reversible damage to
extrahepatic bile ducts, and its toxicity is related to Rhou and Sox17
Orith Waisbourd-Zinman, Schneider Children’s Medical Center of Israel, Sackler Faculty of Medicine
Tel-Aviv University
12:40-12:50 –New FXR mutation leads to intrahepatic cholestasis and liver failure
Mordechai Slae, Hadassah Medical center
12:50-13:00 –Phenotypic features and clinical outcome of pediatric crohn's disease patients with
perianal disease
Firas Rinawi, Institute of Gastroenterology, Nutrition and Liver Diseases, Schneider Children's Medical
Center of Israel, Petach Tikva, Israel
13:00-13:10- Practice Differences in the Diagnosis and Management of Adult and Pediatric Eosinophilic
Esophagitis
Eyal Zifman, Pediatric Gastroenterology Clinic, Pediatric Division, Meir Medical Center, Kfar-Saba, Israel
13:10-13:20- Pediatric Eosinophilic Esophagitis: Results of the Retrospective Pediatric Eosinophilic
Esophagitis Registry (RetroPEER)
Assaf Hoofien, Institute of Gastroenterology, Nutrition and Liver Disease, Schneider Children’s Medical
Center of Israel, Petach Tikva, Israel
13:20-13:30- Prof. Raanan Shamir, President of ESPGHAN
13:30-13:45- Business Meeting
13:45-14:30- Lunch at the Hotel’s restaurant